Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid vs Vancomycin/Cefazolin in Hemodialysis Patients
NCT00108433Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of linezolid in catheter-related bloodstream infection (CRBSI), sponsored by Pfizer. Started Sep 2005; status: terminated.
02
Drugs
linezolid
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00108433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108433.